Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 2, 2007, Pages 197-209

  Faber, Matthijs J ^a   Dalinghaus, Michiel ^a   Lankhuizen, Inge M ^a   Bezstarosti, Karel ^b   Verhoeven, Adrie J M ^b   Duncker, Dirk J ^b   Helbing, Willem A ^a   Lamers, Jos M J ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Congenital heart disease; HSP 27; Hypertrophy; Peroxiredoxin; Proteomics; Right ventricle

Indexed keywords

ANTIOXIDANT; CHAPERONE; CREATINE KINASE; CYTOPLASM PROTEIN; ENOLASE; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXIREDOXIN; PEROXIREDOXIN 2; PEROXIREDOXIN 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FATTY ACID OXIDATION; GLYCOLYSIS; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WORK; HEMODYNAMICS; LUNG ARTERY BANDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CARDIAC OUTPUT; CYTOPLASM; DIMERIZATION; HEART RATE; HEART VENTRICLES; HEAT-SHOCK PROTEINS; HYPERTROPHY; MALE; ORGAN SIZE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPYRUVATE HYDRATASE; PROTEOME; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR PRESSURE;

ANIMALIA;

EID: 34447537944     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.05.002     Document Type: Article

References (42)

1. Wren C., and O'Sullivan J.J. Survival with congenital heart disease and need for follow up in adult life. Heart 85 (2001) 438-443
2. Bolger A.P., Coats A.J., and Gatzoulis M.A. Congenital heart disease: the original heart failure syndrome. Eur. Heart J. 24 (2003) 970-976
3. Faber M.J., Dalinghaus M., Lankhuizen I.M., Bezstarosti K., Dekkers D.H., Duncker D.J., et al. Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics 5 (2005) 2519-2530
4. Faber M.J., Dalinghaus M., Lankhuizen I.M., Steendijk P., Hop W.C., Schoemaker R.G., et al. Right- and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops. Am. J. Physiol.: Heart Circ. Physiol. 291 (2006) H1580-H1586
5. Suga H., and Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ. Res. 35 (1974) 117-126
6. Buttrick P.M., Kaplan M., Leinwand L.A., and Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J. Mol. Cell. Cardiol. 26 (1994) 61-67
7. Schwartz K., Boheler K.R., de la Bastie D., Lompre A.M., and Mercadier J.J. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am. J. Physiol. 262 (1992) R364-R369
8. Feldman A.M., Weinberg E.O., Ray P.E., and Lorell B.H. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ. Res. 73 (1993) 184-192
9. Charlemagne D., Maixent J.M., Preteseille M., and Lelievre L.G. Ouabain binding sites and (Na+,K+)-ATPase activity in rat cardiac hypertrophy. Expression of the neonatal forms. J. Biol. Chem. 261 (1986) 185-189
10. Bishop S.P., and Altschuld R.A. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am. J. Physiol. 218 (1970) 153-159
11. Taegtmeyer H., and Overturf M.L. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 11 (1988) 416-426
12. Massie B.M., Schaefer S., Garcia J., McKirnan M.D., Schwartz G.G., Wisneski J.A., et al. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation 91 (1995) 1814-1823
13. Craig S.P., Day I.N., Thompson R.J., and Craig I.W. Localisation of neurone-specific enolase (ENO2) to 12p13. Cytogenet. Cell Genet. 54 (1990) 71-73
14. Feo S., Oliva D., Barbieri G., Xu W.M., Fried M., and Giallongo A. The gene for the muscle-specific enolase is on the short arm of human chromosome 17. Genomics 6 (1990) 192-194
15. Keller A., Ott M.O., Lamande N., Lucas M., Gros F., Buckingham M., et al. Activation of the gene encoding the glycolytic enzyme beta-enolase during early myogenesis precedes an increased expression during fetal muscle development. Mech. Dev. 38 (1992) 41-54
16. Fletcher L., Rider C.C., Taylor C.B., Adamson E.D., Luke B.M., and Graham C.F. Enolase isoenzymes as markers of differentiation in teratocarcinoma cells and normal tissues of mouse. Dev. Biol. 65 (1978) 462-475
17. Merkulova T., Lucas M., Jabet C., Lamande N., Rouzeau J.D., Gros F., et al. Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins. Biochem. J. 323 Pt 3 (1997) 791-800
18. Keller A., Rouzeau J.D., Farhadian F., Wisnewsky C., Marotte F., and Lamande N. Differential expression of alpha- and beta-enolase genes during rat heart development and hypertrophy. Am. J. Physiol. 269 (1995) H1843-H1851
19. Schott P., Singer S.S., Kogler H., Neddermeier D., Leineweber K., Brodde O.E., et al. Pressure overload and neurohumoral activation differentially affect the myocardial proteome. Proteomics 5 (2005) 1372-1381
20. Cullingford T.E., Wait R., Clerk A., and Sugden P.H. Effects of oxidative stress on the cardiac myocyte proteome: modifications to peroxiredoxins and small heat shock proteins. J. Mol. Cell. Cardiol. 40 (2006) 157-172
21. Guay J., Lambert H., Gingras-Breton G., Lavoie J.N., Huot J., and Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci. 110 Pt 3 (1997) 357-368
22. Kacimi R., Chentoufi J., Honbo N., Long C.S., and Karliner J.S. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc. Res. 46 (2000) 139-150
23. Buermans H.P., Redout E.M., Schiel A.E., Musters R.J., Zuidwijk M., Eijk P.P., et al. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol. Genomics 21 (2005) 314-323
24. Sabri A., and Steinberg S.F. Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol. Cell. Biochem. 251 (2003) 97-101
25. Braun M.U., LaRosee P., Schon S., Borst M.M., and Strasser R.H. Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat. Cardiovasc. Res. 56 (2002) 52-63
26. Braun M.U., Szalai P., Strasser R.H., and Borst M.M. Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes. Cardiovasc. Res. 59 (2003) 658-667
27. Maizels E.T., Peters C.A., Kline M., Cutler Jr. R.E., Shanmugam M., and Hunzicker-Dunn M. Heat-shock protein-25/27 phosphorylation by the delta isoform of protein kinase C. Biochem. J. 332 Pt 3 (1998) 703-712
28. Liu J., Tang M., Mestril R., and Wang X. Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J. Mol. Cell. Cardiol. 40 (2006) 451-454
29. Chavez Zobel A.T., Loranger A., Marceau N., Theriault J.R., Lambert H., and Landry J. Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G alphaB-crystallin mutant. Hum. Mol. Genet. 12 (2003) 1609-1620
30. Connell P., Ballinger C.A., Jiang J., Wu Y., Thompson L.J., Hohfeld J., et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell. Biol. 3 (2001) 93-96
31. Zhang C., Xu Z., He X.R., Michael L.H., and Patterson C. CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am. J. Physiol.: Heart Circ. Physiol. 288 (2005) H2836-H2842
32. Patterson C. Search and destroy: the role of protein quality control in maintaining cardiac function. J. Mol. Cell. Cardiol. 40 (2006) 438-441
33. Wagner E., Luche S., Penna L., Chevallet M., Van Dorsselaer A., Leize-Wagner E., et al. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem. J. 366 (2002) 777-785
34. Rabilloud T., Heller M., Gasnier F., Luche S., Rey C., Aebersold R., et al. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 277 (2002) 19396-19401
35. Mitsumoto A., Takanezawa Y., Okawa K., Iwamatsu A., and Nakagawa Y. Variants of peroxiredoxins expression in response to hydroperoxide stress. Free Radical Biol. Med. 30 (2001) 625-635
36. Baty J.W., Hampton M.B., and Winterbourn C.C. Proteomic detection of hydrogen peroxide-sensitive thiol proteins in Jurkat cells. Biochem. J. 389 (2005) 785-795
37. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radical Biol. Med. 38 (2005) 1543-1552
38. Nagy N., Malik G., Fisher A.B., and Das D.K. Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia reperfusion injury. Am. J. Physiol.: Heart Circ. Physiol. 291 (2006) H2636-H2640
39. Kirshenbaum L.A., Hill M., and Singal P.K. Endogenous antioxidants in isolated hypertrophied cardiac myocytes and hypoxia-reoxygenation injury. J. Mol. Cell. Cardiol. 27 (1995) 263-272
40. Wagner K.D., Gmehling G., Gunther J., Stauss H.M., Mydlak K., Theres H., et al. Contractile function of rat myocardium is less susceptible to hypoxia/reoxygenation after acute infarction. Mol. Cell. Biochem. 228 (2001) 49-55
41. McGregor E., and Dunn M.J. Proteomics of heart disease. Hum. Mol. Genet. 12 Spec No 2 (2003) R135-R144
42. Faber M.J., Agnetti G., Bezstarosti K., Lankhuizen I.M., Dalinghaus M., Guarnieri C., et al. Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure. Cell. Biochem. Biophys. 44 (2006) 11-29